Loading organizations...
§ Private Profile · San Francisco, CA, USA
Fluid technology developer and manufacturer of precision fluid control components for microfluidics, serving life sciences and industrial automation.
Based in Shenzhen, Guangdong, China, Keyto develops and manufactures precision fluid control components and systems, including micro solenoid valves, miniature diaphragm pumps, and liquid handling components for accurate flow control in microfluidics. Its solutions cater to applications across life sciences, in vitro diagnostics, pathology, medical recovery, and laboratory automation. Serving over 3,500 innovators globally, Keyto provides precise liquid management for industrial and applied sciences, diagnostics, and environmental monitoring. Keyto, founded in 2010 by Mr. Zhang, holds over 100 patents and copyrights, demonstrating fully independent intellectual property. Notably, the firm produced proportional valves for ventilators, a key technological breakthrough during the COVID-19 pandemic. Its business model centers on sectors/customers: Industrial and applied sciences, diagnostics, lab solutions, life sciences, and environmental monitoring, serves 3,500+ innovators globally.
Keyto has raised $17.3M across 2 funding rounds.
Keyto has raised $17.3M in total across 2 funding rounds.
Keyto has raised $17.3M in total across 2 funding rounds.
Keyto's investors include David O. Sacks, Julia Hartz, Kevin Hartz, Abstract Ventures, Floodgate, Hydra Ventures.
Keyto Fluid Technology Co., Ltd. is a manufacturer specializing in the development, production, and customization of precision fluid control components and system solutions, including solenoid valves, rotary shear valves, air displacement pipettes, sampling pumps, diaphragm pumps, manifolds, microfluidic chips, and fluidic connections.[1][3][5] It serves industries such as medical devices, life sciences, biopharma, environmental monitoring, industrial automation, IVD (in vitro diagnostics), POCT (point-of-care testing), laboratory automation, and semiconductors, solving challenges in precise microfluidic control for diagnostics, analysis, and fluid handling.[1][3] Founded in 2010, the company has grown to over 550 global employees, 100+ patents and copyrights, 5000+ customers, a 28,000 sqm manufacturing facility, and 4 branch offices, demonstrating strong growth momentum through innovations like custom integrated fluidic modules.[1][3]
Keyto Fluid Technology was founded in 2010 in China as a specialist in critical fluid control components, drawing on over a decade of supply chain experience in IVD, diagnostics, medical, chemical, and environmental fields.[1][3] The founders leveraged expertise in microfluidics to address technical limitations in precision control, evolving from component manufacturing to a one-stop partner offering integrated R&D, production, sales, and systematic solutions.[3] Early traction came from reliable product design and quality control in advanced microfluid analysis, positioning Keyto as a leader in China with a competitive product range; pivotal moments include expanding to global markets and accumulating 100+ patents amid growing demand for lab automation and diagnostics.[1][3]
Keyto rides the wave of microfluidics and lab-on-a-chip trends, enabling miniaturization from traditional testing to portable diagnostics amid rising demand for POCT, biopharma automation, and environmental monitoring.[1][3] Timing aligns with post-pandemic acceleration in IVD and life sciences, where precise fluid control is critical for rapid analysis and scalability; market forces like semiconductor integration and green automation favor its solutions.[3] As a prime player in China with global reach, Keyto influences the ecosystem by supplying reliable components to diagnostics innovators, fostering advancements in precision medicine and lab efficiency.[1][5]
Keyto is poised for expansion through microfluidics innovations like integrated modules for POCT and lab automation, capitalizing on biopharma growth and AI-driven diagnostics.[1][3] Trends in portable labs, sustainable monitoring, and semiconductor microfluidics will shape its trajectory, potentially boosting its 5000+ customer base via new patents and facilities. Its influence may evolve as a global enabler of next-gen fluid systems, solidifying leadership from precision components to full ecosystems—empowering the diagnostics revolution that defines its origins.[1][3]
Keyto has raised $17.3M across 2 funding rounds. Most recently, it raised $14.8M Series C in January 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 19, 2023 | $14.8M Series C | — | — | Announced |
| Nov 27, 2018 | $2.5M Seed | David O. Sacks | Julia Hartz, Kevin Hartz, Abstract Ventures, Floodgate, Hydra Ventures | Announced |